Hey PRIME-mates,
This is an article from the San Francisco Chronicle about potential changes in the pharmaceutical market now that Obama has been elected. Obama's proposed changes to the industry include more widespread use of generic drugs, import of lower cost drugs from other countries, and a pharmaceutical price break negotiated for Medicare.
The Biotech Industry Organization is analyzing the financial impact of these types of changes. They've already started to cite our country's economic troubles as a legitimate reason to keep drug prices high. Is revitalizing the economy really more important than treating the sick people who these drugs were developed for (often with publicly funded money from the NIH)?? Check it out:
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/11/08/BU9H13UVDA.DTL&type=politics
Ok, back to biochem....
-Nicole
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment